Developer docs
API playgroundTry for free, no card

Search company profiles

Sevenpoint One

Full company profile

uuid0004ccv

Namestring
Sevenpoint One
Legal namestring
주식회사 세븐포인트원 (Seven Point One Inc.)
Websiteurl
sevenptone.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Sevenpoint One (세븐포인트원) is a South Korea-based digital healthcare company founded in 2017 that develops AI-powered and XR-based solutions for early dementia detection and cognitive health management. Its flagship product AlzWIN is a speech-based cognitive assessment that completes in approximately one minute, uses proprietary NLP and speech analysis algorithms trained on clinical trial data, and is certified under ISO 13485 and GMP for medical device quality. Its second product, SENTENTS, combines extended reality (XR) technology with cognitive behavioral therapy principles to deliver immersive therapeutic experiences aimed at reducing depression (reported 66.9% reduction) and increasing well-being (reported 86% happiness increase) among elderly users.

The company operates a B2B2C go-to-market model, distributing AlzWIN through healthcare institutions including memory clinics, dementia care centers, and occupational therapy practices, while SENTENTS is offered via healthcare and wellness partnerships. Sevenpoint One maintains a broad institutional partnership ecosystem in Korea spanning life insurance (Hanwha Life, Samsung Life), major hospitals (Asan Medical Center, Seoul National University Bundang Hospital), pharmaceutical companies (Eisai), technology platforms (Naver), and public health programs (Gyeonggi-do province). Revenue is generated through subscription/recurring arrangements with healthcare institutions, though specific pricing is not publicly disclosed. The company has a US sales/operations office in Seattle, Washington alongside its Korean headquarters in Seoul, and was recognized by AARP's AgeTech Collaborative in 2025 as one of six startups innovating in brain health.

With 11-50 employees, the company remains early-stage: total disclosed funding to date is approximately $187,472 (a 2021 round with CNTTECH, NAVER D2SF, and other Korean investors), supplemented by an undisclosed 2025 XLIMIT Accelerator participation. The company is privately held and founder-led, with no disclosed institutional investors beyond CNT Tech.

Short descriptiontext

Sevenpoint One is a South Korea-based digital healthcare company founded in 2017 that offers AlzWIN, an AI-powered one-minute speech-based cognitive assessment for early dementia detection, and SENTENTS, an XR-based therapeutic platform, sold through healthcare institutions, insurers, and public health partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cognitive health assessment, dementia screening software, speech-based diagnostics, XR mental health therapy, brain health platform
Industry3 codes
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHSABAEAH
Cognitive Stimulation & Reminiscence Therapy (Non-Clinical)
Home & Personal Services/Elder Care & In-Home Care Services/Dementia & Alzheimer’s In-Home Care
SECONDARYHLADALAF
Dementia/Alzheimer’s Care Management & Behavioral Support
Healthcare & Life Sciences/Elder Care & Long-Term Care/Senior Care Coordination & Case Management (Geriatric Care Management)
NAICS code1 code
  • Services for the Elderly and Persons with Disabilities62412
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Digital Health - Cognitive Assessment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1AlzWIN Cognitive Assessment Services
TypeSubscription Recurring
Description

AI-powered speech-based cognitive assessment tool delivered to healthcare institutions and memory clinics. Healthcare providers administer the test to patients, with results used for early dementia detection and screening.

sevenptone.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1AlzWIN
Description

AI-powered cognitive assessment solution for rapid brain health screening and dementia detection. Offers one-minute speech-based testing with ISO 13485 and GMP quality certifications.

sevenptone.com
+1 more record
Core offering1 text field

Sevenpoint One develops and sells AlzWIN, an AI-powered one-minute speech-based cognitive assessment tool for early dementia detection, and SENTENTS, an XR-based therapy platform that uses cognitive behavioral therapy principles to reduce depression and improve well-being in elderly users. Both products are delivered to healthcare institutions and clinical partners under a B2B2C subscription model.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 66.9% reduction in depression symptoms with SENTENTS XR therapy
+4 more records
Product overview1 text field

Sevenpoint One offers a dual-product portfolio focused on digital brain health solutions. The core offerings are: (1) AlzWIN — an AI-powered speech-based cognitive assessment tool for rapid dementia screening, and (2) SENTENTS — an XR-based therapeutic platform for depression and cognitive decline prevention using cognitive behavioral therapy. Together, these products address the full spectrum from early detection (AlzWIN) to intervention and prevention (SENTENTS), enabling healthcare providers and individuals to manage brain health proactively.

Product and service2 records
1AlzWIN
CategoryAI Cognitive Assessment Software
Description

AI-powered cognitive health assessment solution that uses speech-based testing to evaluate brain health in approximately one minute. The solution is designed for accessibility for users aged 60 and above, with clinical validation for identifying cognitive decline and Alzheimer's disease. Distributed to memory clinics, dementia care centers, occupational therapy practices, and public health programs.

2SENTENTS
CategoryXR Mental Health Therapy
Description

XR-based solution combining extended reality technology with cognitive behavioral therapy principles to help users recall happy memories, reduce depression, and improve happiness in elderly users. Features real-time multi-playback functionality with elderly-friendly UI/UX design.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeGTM or Marketing Partner
Description

Seven Point One was selected as one of six startups to be spotlighted by the AgeTech Collaborative from AARP during Alzheimer's & Brain Awareness Month, highlighting innovative brain health solutions including AI-powered cognitive assessments and VR-based brain training.

2Eisai
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Eisai, a pharmaceutical company, on brain health solutions. Eisai has developed dementia treatments including donanemab and lecanemab that align with Seven Point One's early diagnosis focus.

sevenptone.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Gyeonggi-do province for healthcare services, utilizing AlzWIN for early dementia screening in public health programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical collaboration with SNUBH for validation and adoption of cognitive assessment technology in hospital settings.

5Hanwha Life
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Hanwha Life Insurance for brain health assessment integration with insurance and healthcare services.

sevenptone.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Samsung Life Insurance for brain health assessment integration with insurance services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical collaboration with Asan Medical Center for validation and implementation of cognitive assessment technology.

8Korean Association of University Hospitals of Health and Welfare (CAUHS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with university healthcare network for research and clinical implementation of brain health solutions.

sevenptone.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Digital cognitive assessment platform using speech, AI, and digital biomarkers for early dementia detection. Highly comparable to AlzWIN in product category, target buyers (clinicians and health systems), and use case (screening for cognitive decline).

TypeDirect peer
Description

Provides computerized cognitive assessment tools widely used in clinical trials, healthcare, and research. Directly comparable to AlzWIN as a digital cognitive testing platform serving healthcare and research customers.

TypeDirect peer
Description

Developer of CANTAB cognitive assessment software for clinical trials, healthcare, and academic research. Comparable to AlzWIN in delivering validated, computerized cognitive assessments to clinicians and researchers.

TypeDirect peer
Description

Digital cognitive assessment platform used by clinicians for rapid screening and tracking of cognitive function. Closely comparable to AlzWIN in product (rapid cognitive screening) and target market (US-based clinicians and health systems).

TypeDirect peer
Description

AI-driven digital cognitive assessment platform with FDA clearance, focused on early detection of Alzheimer's and other neurodegenerative conditions. Comparable to AlzWIN in approach (AI-based digital assessment) and condition focus (Alzheimer's/dementia).

TypeDirect peer
Description

Digital cognitive health company offering screening and longitudinal monitoring for memory and cognitive decline. Comparable to AlzWIN in product positioning (digital screening for cognitive decline) and end-user focus (seniors concerned about memory).

7XRHealth
TypeDirect peer
Description

VR-based therapeutic platform for physical and cognitive rehabilitation, including conditions common in older adults. Comparable to SENTENTS in modality (extended reality therapy) and target population (patients with cognitive/behavioral conditions).

TypeDirect peer
Description

VR-based digital therapeutics for mental and behavioral health, including anxiety and depression. Comparable to SENTENTS in using immersive XR experiences as a therapeutic modality for mental health outcomes.

TypeEmerging player
Description

Diagnostics company focused on Alzheimer's disease detection via blood-based biomarkers (PrecivityAD). Adjacent peer to AlzWIN in the Alzheimer's early-diagnosis category but using a different (lab-based blood test) modality.

TypeBroad incumbent
Description

Global diagnostics and pharmaceutical incumbent developing Elecsys Alzheimer's disease biomarkers and broader digital health initiatives. Comparable as a large incumbent in the Alzheimer's diagnostics and care pathway where Seven Point One is positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sevenpoint One

Digital Health - Cognitive Assessmentsevenptone.com

Sevenpoint One is a South Korea-based digital healthcare company founded in 2017 that offers AlzWIN, an AI-powered one-minute speech-based cognitive assessment for early dementia detection, and SENTENTS, an XR-based therapeutic platform, sold through healthcare institutions, insurers, and public health partners.

What Sevenpoint One does

Sevenpoint One (세븐포인트원) is a South Korea-based digital healthcare company founded in 2017 that develops AI-powered and XR-based solutions for early dementia detection and cognitive health management. Its flagship product AlzWIN is a speech-based cognitive assessment that completes in approximately one minute, uses proprietary NLP and speech analysis algorithms trained on clinical trial data, and is certified under ISO 13485 and GMP for medical device quality. Its second product, SENTENTS, combines extended reality (XR) technology with cognitive behavioral therapy principles to deliver immersive therapeutic experiences aimed at reducing depression (reported 66.9% reduction) and increasing well-being (reported 86% happiness increase) among elderly users.

The company operates a B2B2C go-to-market model, distributing AlzWIN through healthcare institutions including memory clinics, dementia care centers, and occupational therapy practices, while SENTENTS is offered via healthcare and wellness partnerships. Sevenpoint One maintains a broad institutional partnership ecosystem in Korea spanning life insurance (Hanwha Life, Samsung Life), major hospitals (Asan Medical Center, Seoul National University Bundang Hospital), pharmaceutical companies (Eisai), technology platforms (Naver), and public health programs (Gyeonggi-do province). Revenue is generated through subscription/recurring arrangements with healthcare institutions, though specific pricing is not publicly disclosed. The company has a US sales/operations office in Seattle, Washington alongside its Korean headquarters in Seoul, and was recognized by AARP's AgeTech Collaborative in 2025 as one of six startups innovating in brain health.

With 11-50 employees, the company remains early-stage: total disclosed funding to date is approximately $187,472 (a 2021 round with CNTTECH, NAVER D2SF, and other Korean investors), supplemented by an undisclosed 2025 XLIMIT Accelerator participation. The company is privately held and founder-led, with no disclosed institutional investors beyond CNT Tech.

Sevenpoint One firmographics

Firmographics
Name
Sevenpoint One
Legal name
주식회사 세븐포인트원 (Seven Point One Inc.)
Website
https://sevenptone.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
Sevenpoint One is a South Korea-based digital healthcare company founded in 2017 that offers AlzWIN, an AI-powered one-minute speech-based cognitive assessment for early dementia detection, and SENTENTS, an XR-based therapeutic platform, sold through healthcare institutions, insurers, and public health partners.
Ownership category
akta.pro rank

Sevenpoint One industry classification

Industry
Product category
Digital Health - Cognitive Assessment
NAICS
Services for the Elderly and Persons with Disabilities (62412)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHSABAEAH
Cognitive Stimulation & Reminiscence Therapy (Non-Clinical)
Home & Personal Services/Elder Care & In-Home Care Services/Dementia & Alzheimer’s In-Home Care
SECONDARYHLADALAF
Dementia/Alzheimer’s Care Management & Behavioral Support
Healthcare & Life Sciences/Elder Care & Long-Term Care/Senior Care Coordination & Case Management (Geriatric Care Management)

Keywords

  • Cognitive health assessment
  • Dementia screening software
  • Speech-based diagnostics
  • XR mental health therapy
  • Brain health platform

Where Sevenpoint One is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices2 records

Markets served

Sevenpoint One business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. AlzWIN Cognitive Assessment Services: AI-powered speech-based cognitive assessment tool delivered to healthcare institutions and memory clinics. Healthcare providers administer the test to patients, with results used for early dementia detection and screening.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Sevenpoint One product offering

Product offering

Core offering

Sevenpoint One develops and sells AlzWIN, an AI-powered one-minute speech-based cognitive assessment tool for early dementia detection, and SENTENTS, an XR-based therapy platform that uses cognitive behavioral therapy principles to reduce depression and improve well-being in elderly users. Both products are delivered to healthcare institutions and clinical partners under a B2B2C subscription model.

Product overview

Sevenpoint One offers a dual-product portfolio focused on digital brain health solutions. The core offerings are: (1) AlzWIN — an AI-powered speech-based cognitive assessment tool for rapid dementia screening, and (2) SENTENTS — an XR-based therapeutic platform for depression and cognitive decline prevention using cognitive behavioral therapy. Together, these products address the full spectrum from early detection (AlzWIN) to intervention and prevention (SENTENTS), enabling healthcare providers and individuals to manage brain health proactively.

Differentiator

Problem solved

Functional benefit

Brands

  • AlzWIN: AI-powered cognitive assessment solution for rapid brain health screening and dementia detection. Offers one-minute speech-based testing with ISO 13485 and GMP quality certifications.
  • SENTENTS

Products and services

  • AlzWIN AI-powered cognitive health assessment solution that uses speech-based testing to evaluate brain health in approximately one minute. The solution is designed for accessibility for users aged 60 and above, with clinical validation for identifying cognitive decline and Alzheimer's disease. Distributed to memory clinics, dementia care centers, occupational therapy practices, and public health programs.
  • SENTENTS XR-based solution combining extended reality technology with cognitive behavioral therapy principles to help users recall happy memories, reduce depression, and improve happiness in elderly users. Features real-time multi-playback functionality with elderly-friendly UI/UX design.

Quantifiable outcome

  • 66.9% reduction in depression symptoms with SENTENTS XR therapy
  • +4 more outcomes

Companies that use Sevenpoint One

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles3 records

Sevenpoint One technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature2 records

Sevenpoint One partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • AgeTech Collaborative from AARPcoreGTM or Marketing PartnerSeven Point One was selected as one of six startups to be spotlighted by the AgeTech Collaborative from AARP during Alzheimer's & Brain Awareness Month, highlighting innovative brain health solutions including AI-powered cognitive assessments and VR-based brain training.
  • EisaicoreStrategic or Co-development PartnerCollaboration with Eisai, a pharmaceutical company, on brain health solutions. Eisai has developed dementia treatments including donanemab and lecanemab that align with Seven Point One's early diagnosis focus.
  • Gyeonggi-docoreStrategic or Co-development PartnerPartnership with Gyeonggi-do province for healthcare services, utilizing AlzWIN for early dementia screening in public health programs.
  • Seoul National University Bundang Hospital (SNUBH)coreStrategic or Co-development PartnerClinical collaboration with SNUBH for validation and adoption of cognitive assessment technology in hospital settings.
  • Hanwha LifecoreStrategic or Co-development PartnerPartnership with Hanwha Life Insurance for brain health assessment integration with insurance and healthcare services.
  • Samsung LifecoreStrategic or Co-development PartnerPartnership with Samsung Life Insurance for brain health assessment integration with insurance services.
  • Asan Medical CentercoreStrategic or Co-development PartnerClinical collaboration with Asan Medical Center for validation and implementation of cognitive assessment technology.
  • Korean Association of University Hospitals of Health and Welfare (CAUHS)coreStrategic or Co-development PartnerPartnership with university healthcare network for research and clinical implementation of brain health solutions.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Sevenpoint One competitors and assessment

Company assessment

Direct peers

  • Linus Health: Digital cognitive assessment platform using speech, AI, and digital biomarkers for early dementia detection. Highly comparable to AlzWIN in product category, target buyers (clinicians and health systems), and use case (screening for cognitive decline).
  • Cogstate: Provides computerized cognitive assessment tools widely used in clinical trials, healthcare, and research. Directly comparable to AlzWIN as a digital cognitive testing platform serving healthcare and research customers.
  • Cambridge Cognition: Developer of CANTAB cognitive assessment software for clinical trials, healthcare, and academic research. Comparable to AlzWIN in delivering validated, computerized cognitive assessments to clinicians and researchers.
  • BrainCheck: Digital cognitive assessment platform used by clinicians for rapid screening and tracking of cognitive function. Closely comparable to AlzWIN in product (rapid cognitive screening) and target market (US-based clinicians and health systems).
  • Altoida: AI-driven digital cognitive assessment platform with FDA clearance, focused on early detection of Alzheimer's and other neurodegenerative conditions. Comparable to AlzWIN in approach (AI-based digital assessment) and condition focus (Alzheimer's/dementia).
  • Neurotrack: Digital cognitive health company offering screening and longitudinal monitoring for memory and cognitive decline. Comparable to AlzWIN in product positioning (digital screening for cognitive decline) and end-user focus (seniors concerned about memory).
  • XRHealth: VR-based therapeutic platform for physical and cognitive rehabilitation, including conditions common in older adults. Comparable to SENTENTS in modality (extended reality therapy) and target population (patients with cognitive/behavioral conditions).
  • BehaVR: VR-based digital therapeutics for mental and behavioral health, including anxiety and depression. Comparable to SENTENTS in using immersive XR experiences as a therapeutic modality for mental health outcomes.

Emerging players

  • C2N Diagnostics: Diagnostics company focused on Alzheimer's disease detection via blood-based biomarkers (PrecivityAD). Adjacent peer to AlzWIN in the Alzheimer's early-diagnosis category but using a different (lab-based blood test) modality.

Broad incumbents

  • Roche Diagnostics: Global diagnostics and pharmaceutical incumbent developing Elecsys Alzheimer's disease biomarkers and broader digital health initiatives. Comparable as a large incumbent in the Alzheimer's diagnostics and care pathway where Seven Point One is positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Sevenpoint One social profiles

Digital presence

Sevenpoint One compliance and trust

Trust signal

Compliance2 records

Sevenpoint One financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sevenpoint One leadership team

Management profile

Number of profiles

Profiles2 records

Sevenpoint One funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sevenpoint One M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sevenpoint One

What does Sevenpoint One do?

Sevenpoint One develops and sells AlzWIN, an AI-powered one-minute speech-based cognitive assessment tool for early dementia detection, and SENTENTS, an XR-based therapy platform that uses cognitive behavioral therapy principles to reduce depression and improve well-being in elderly users. Both products are delivered to healthcare institutions and clinical partners under a B2B2C subscription model.

Is Sevenpoint One a public or private company?

Sevenpoint One is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sevenpoint One founded?

Sevenpoint One was founded in 2017. It employs 1 to 10 people.

Where is Sevenpoint One based?

Sevenpoint One is headquartered in Seoul, South Korea, in the Asia region.

How does Sevenpoint One make money?

One revenue line is on record: alzWIN Cognitive Assessment Services.

Who are Sevenpoint One's main competitors?

Direct peers on record are Linus Health, Cogstate, Cambridge Cognition, BrainCheck, Altoida, Neurotrack, XRHealth and BehaVR. C2N Diagnostics is listed as an emerging player. Roche Diagnostics is listed as a broad incumbent.

Does Sevenpoint One have an API?

No public API is recorded for Sevenpoint One.

What industry is Sevenpoint One in?

Sevenpoint One's product category is Digital Health - Cognitive Assessment. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HSABAEAH, Cognitive Stimulation & Reminiscence Therapy (Non-Clinical). Its NAICS code is 62412 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals